Substance Use Screening Among Drug User

Overview

The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.

Full Title of Study: “Screening and Brief Interventions for Substance Use in Primary Medical Institution”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2018

Detailed Description

In order to reduce the social and personal harm caused by drugs, it is urgent to strengthen the ability of the primary health institutions in screening and intervention the addictive substances use. Firstly, the investigators will invite 10 primary medical staffs and 10 experts in addition to revise the manual of Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST) and Brief Intervention (BI). Then, the investigators will recruit 100 medical staffs to participate the training of ASSIST and BI. Secondly, the researcher will investigate the effects of BI technology in reducing the use of addictive substances, improve the addiction related knowledge of patients through randomized controlled study. Finally, the investigators will collect the research information, revise the manual, and promote the training.

Interventions

  • Behavioral: Intervention Group
    • The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.
  • Behavioral: Control Group
    • The participants only receive the materials about the harm of substance use.

Arms, Groups and Cohorts

  • Experimental: Intervention Group
    • The medical staffs who received the training will use the manual of brief intervention to deliver it and other materials about the harm of substance use.
  • Active Comparator: Control Group
    • The participants only receive the materials about the harm of substance use.

Clinical Trial Outcome Measures

Primary Measures

  • Risk Behaviors measured by ASSIST questionnaire
    • Time Frame: 1 month
    • Risk Behaviors will be measured by ASSIST questionnaire.
  • Knowledge related to Substance Use measured by Knowledge related to Addiction questionnaire
    • Time Frame: 1 month
    • Knowledge related to substance use will be measured by Knowledge related to Addiction questionnaire.
  • Motivation measured by Pre-treatment Readiness Scale
    • Time Frame: 1 month
    • Motivation will be measured by Pre-treatment Readiness Scale (PRS).

Secondary Measures

  • Depression measured by Self-Rating Depression Scale
    • Time Frame: 1 month
    • the change of depression will be measured by Self-Rating Depression Scale (SDS).
  • Anxiety measured by Self-Rating Anxiety Scale
    • Time Frame: 1 month
    • the change of anxiety will be measured by Self-Rating Anxiety Scale (SAS).
  • Self-esteem measured by Self-esteem questionnaire
    • Time Frame: 1 month
    • the change of self-esteem will be measured by Self-esteem questionnaire.

Participating in This Clinical Trial

Inclusion Criteria

1. aged 18-60 years; 2. the patient to the community medical institutions; 3. ASSIST score is in 12-27, in a moderate risk; 4. voluntary to participate; 5. to agree to complete baseline interviews and follow-up studies. Exclusion Criteria:

1. unable to complete the questionnaire; 2. serious physical illness, action inconvenience.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Shanghai Mental Health Center
  • Provider of Information About this Clinical Study
    • Principal Investigator: DU, Jiang, Cheif Physician – Shanghai Mental Health Center
  • Overall Official(s)
    • Jiang Du, M.D, Principal Investigator, Shanghai Mental Health Center
  • Overall Contact(s)
    • Jiang Du, M.D, 18017311220, dujiangdou@163.com

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.